Page 382 - Read Online
P. 382

Fang et al.                                                                                                                                 Negative pressure wound therapy for diabetic foot limb salvage

           Table 1: Patient characteristics of PAD group (No. 1-10) and non-PAD comparison group (No. 11-13)
            No. of   Age   Gender  Admission   Comorbidities  DDY  Wound size   Wound   No. of VAC  Treatment  Follow   DFUS  Result
                                                             3
            subject  (years)  length (days)               (cm /cm ) 2  location  application  time  up (days)
                                                                  Left dorsal                        Spontaneous
            1      36   Male    64     PAD, osteomyelitis  9  12 × 4 × 1      3       9     57    1
                                                                     foot                              closure
                                       PAD, osteomyelitis,                                           Spontaneous
            2      40   Male    63                    9     7 × 3  Right plantar  5  15     114   3
                                         ESRD, HTN                                                     closure
                                       PAD, osteomyelitis,        Left dorsal                        Spontaneous
            3      64   Male    56                   15    15 × 7             5      15     50    3
                                          HTN, CVA                   foot                              closure
                                                                  Left dorsal                        Spontaneous
            4      65   Male    46         PAD       23   11 × 4 × 3          6      18     85    2
                                                                     foot                              closure
                                       PAD, osteomyelitis,        Left dorsal                        Spontaneous
            5      70   Male    45                    8   4 × 7 × 0.5         3       9     122   2
                                       ESRD, HTN, CAD                foot                              closure
                                                                                                      Closure with
            6      50   Male    69         PAD       20   20 × 15 × 1  Multiple  6   18     108   4    skin graft
                                       PAD, osteomyelitis,
            7      61   Male    27                   10    1.5 × 1.5  Left plantar  1  3    211   2   Improved*
                                           HTN
                                       PAD, osteomyelitis,                                            Extended
            8      65   Male    39                    10   17 × 7  Left plantar  2    6     39    3
                                       ESRD, CAD, HTN                                                  infection
                                       PAD, osteomyelitis,
            9      73   Male    68                    18    6 × 3  Right toe  5      15     121   3   Amputation
                                       ESRD, CAD, HTN
                                       PAD, osteomyelitis,                                            Expired due
            10     60   Male    103                   20  11 × 3 × 2  Right heel  13  39    20    3
                                       ESRD, HTN, CVA                                                  to sepsis
                                        Osteomyelitis,                                               Spontaneous
            11     69   Male    86                   15     5 × 4  Left heel  7      21     86    2
                                       ESRD, HTN, CVA                                                  closure
                                                                  Left dorsal
            12     51   Male    94     Osteomyelitis, HTN  11  11 × 7.5      12      36     384   2   Improved
                                                                     foot
                                                                  Right dorsal
            13     55   Male    60     Osteomyelitis, HTN  20  10 × 5        11      33     388   2   Improved
                                                                     foot
                 58.38 ±     63.08 ± 21.78          14.46 ±                6.08 ± 3.80  18.23 ±   137.31 ±
                  11.42                              5.25                           11.39  120.38
           *Improved is defined as limb salvage within half a year, but has not achieved wound closure. DDY: diabetes diagnosis year; DFUS: diabetic
           foot ulcer score; PAD: peripheral arterial disease; ESRD: end stage renal disease; HTN: hypertension; CVA: cerebrovascular accident;
           CAD: coronary arterial disease; OSSA: oxacillin-sensitive staphylococcus aureus; MRSA: methicillin-resistant staphylococcus aureus
           Table 2: Subjects with PAD compare with non-PAD in   Table 3: Subjects with limb salvaged versus limb loss
           wound characteristic and NPWT application
                                                              Variable            Limb salvaged (n = 7)  Limb loss (n = 3)

           Variable            PAD (n = 10)  Non-PAD (n = 3)  P  Age (years)         55.14 ± 13.25  66.00 ± 6.56
           Age (years)         58.40 ± 10.18  58.33 ± 9.45    DDY                    13.43 ± 6.02  16.00 ± 5.29
                                                                        2
           DDY                 14.20 ± 5.67  15.33 ± 4.51     Wound area (cm )      78.32 ± 102.92  56.67 ± 54.50
           Wound area (cm ) 2  71.83 ± 93.44  50.83 ± 31.26   Texas grading           1 D2, 6 D3      3 D3
           Texas grading        1 D2, 9 D3  1 B2, 2 B3        DFUS                    2.43 ± 0.98   3.00 ± 0.00
           DFUS                2.60 ± 0.67  2.00 ± 0.00       Number of NPWT application  4.14 ± 1.86  6.67 ± 5.69
           No. of NPWT application  4.90 ± 3.44  10.00 ± 2.65  < 0.05  NPWT treatment (days)  12.43 ± 5.59  20.00 ± 17.06
           NPWT treatment (days)  14.70 ± 10.33  30.00 ± 7.94  < 0.05  Hospital admission (days)  52.86 ± 14.58  70.00 ± 32.05
           Hospital admission (days)  64.44 ± 22.10  60.00 ± 17.78  Data shown as mean ± SD. DDY: diabetes diagnosis year; DFUS:
           Limb salvage (%)      70%*         100%            diabetic foot ulcer score; NPWT: negative pressure wound therapy
           *3 infection complications resulting in 1 mortality, 1 amputation, and
           1 transfer. Data shown as mean ± SD. DDY: diabetes diagnosis   osteomyelitis. Repeated and frequent debridement
           year; DFUS: diabetic foot ulcer score; PAD: peripheral arterial
           disease; NPWT: negative pressure wound therapy     for infection control created a vicious cycle for
                                                              these patients, as frequent debridement often led to
           features between patients who had limb salvage and   inevitable limb amputation if there was no strategy for
           those who did not [Table 3].                       reconstruction due to poor circulation. In this situation,
                                                              it is reasonable to apply NPWT as an adjuvant therapy
           DISCUSSION                                         to achieve limb salvage. Although there have been
                                                              few studies on the benefits of NPWT in the treatment
           PAD is a known risk factor for diabetic foot       of diabetic foot ulcers in the last 10 years, [1,20]  this
           amputation, [22]  with a 29% amputation rate and 55%   is the first study to focus on limb salvage following
           5-year mortality associated with ischemic DFU. [17]    NPWT in patients with diabetic foot ulcers and PAD.
           Our studies have also shown that many diabetic     The current study shows a 70% limb salvage rate in a
           patients present with PAD in combination with other   group of patients with higher wound severity.
           comorbidities, including hypertension (70%) and end
           stage renal disease (50%). Patients with DFU and   Previous studies have demonstrated that NPWT
           PAD usually had poor infection control, hence the   may facilitate wound healing through extracellular,
           majority of cases presented with deep infections with   cellular and complex effects via increased blood

                           Plastic and Aesthetic Research ¦ Volume 3 ¦ December 20, 2016                  381
   377   378   379   380   381   382   383   384   385   386   387